Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Personalised Medicine Market Outlook

The global personalised medicine market size was estimated at USD 2.48 trillion in 2023 and is expected to grow over the forecast period of 2024-2032 at a CAGR of 11.2%. Personalised medicine promises a paradigm shift in the delivery of diagnosis as the therapy care is based on the information leveraged from an individual patient’s holistic perspective.

Global Personalised Medicine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Segmentation

Personalised medicine is a kind of medical care in which treatment is customised for an individual patient. The global personalised medicine market can be divided based on segments like technology, application, and product.

Global Personalised Medicine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The personalised medicine market can be broadly categorised based on its application into:

  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Other

The industry can be divided on the basis of its technology like big data analytics, bioinformatics, gene sequencing, drug discovery, and companion diagnostics, among others. The industry can be divided based on its product as PM diagnostics, PM therapeutics, personalised medical care, and personalised nutrition and wellness. PM diagnostics is subdivided into genetic testing, direct-to-consumer (DTC) diagnostics, esoteric lab services, and esoteric lab tests. PM therapeutics is also further subdivided into pharmaceuticals, genomic medicine, and medical devices. Personalised medical care, meanwhile, is subdivided into telemedicine, health information technology, and disease management. Personalised nutrition and wellness can be further categorised into retail nutrition, complementary medicine, and alternative medicine.

The EMR report looks into the regional markets of personalised medicine like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.

Market Analysis

The proliferation of sequencing methodologies, in particular, Next Generation Sequencing, is anticipated to drive the personalised medicine market growth owing to the increasing sequencing costs and the growth of the Human Genome Project in the field of genomics. Increasing cancer incidence, which boosts the demand for personalised diagnosis of cancer and therapy, is also one of the main variables responsible for the personalised medicine market growth. The growing expenditure on cancer is also one of the drivers for the development of the personalised medicine market.

Global Personalised Medicine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

The report presents a detailed analysis of the following key players in the global personalised medicine market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Illumina Inc.         
  • GE Healthcare  
  • Pfizer Inc.  
  • Novartis AG     
  • Abbott Laboratories    
  • Asuragen Inc.    
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Technology
  • Application
  • Product
  • Region
Breakup by Technology
  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Others
Breakup by Application
  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Others
Breakup by Product
  • PM Diagnostics
  • PM Therapeutics
  • Personalised Medical Care
  • Personalised Nutrition and Wellness
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Illumina Inc.
  • GE Healthcare
  • Pfizer Inc.
  • Novartis AG
  • Abbott Laboratories
  • Asuragen Inc.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

In 2023, the global personalised medicine market attained a value of nearly USD 2.48 trillion.

The market is estimated to witness a healthy growth, expanding at a CAGR of 11.2% in the forecast period of 2024-2032.

The major drivers of the market include the advancements in sequencing methodologies, paradigm shift in the delivery of diagnosis, and the growth of the human genome project in the field of genomics.

The increasing prevalence of cancer is boosting the demand for personalised medical care and therapy, which is expected to be a key trend guiding the growth of the industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Big data analytics, bioinformatics, gene sequencing, drug discovery, and companion diagnostics, among others are the major technologies of the product in the market.

PM diagnostics (genetic testing, direct-to-consumer (DTC) diagnostics, esoteric lab services, and esoteric lab tests), PM therapeutics (pharmaceuticals, genomic medicine, and medical devices), personalised medical care (telemedicine, health information technology, and disease management), and personalised nutrition and wellness (retail nutrition, complementary medicine, and alternative medicine) are the different products available in the market.

Oncology, CNS, immunology, and respiratory, among others are the significant applications of the product in the market.

The major players in the industry are Illumina Inc., GE Healthcare, Pfizer Inc., Asuragen Incorporated, Novartis AG, Abbott Laboratories, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124